Lucas Ferrer Cardona, MD
Vascular Surgery · San Antonio, TXNPI 1790912244
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Surmodics, Inc. at 46.3% of the total. Among vascular surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 590 payments — averaging $238.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Surmodics, Inc.$65K
- Angiodynamics, Inc.$30K
- Medtronic$15K
- Penumbra, Inc.$11K
- Bard Peripheral Vascular, Inc.$3K
- W. L. Gore & Associates, Inc.$3K
- plus $12K from 32 others
Across 11 payments — averaging $7455.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Surmodics, Inc.$82K
What the payments were for
- Consulting fees$72,15051%
- Speaking & faculty fees$4,8003%
- Travel & lodging$29,15221%
- Food & beverage$34,65525%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Surmodics, Inc. | 104 | $65,132 |
| Angiodynamics, Inc. | 73 | $29,988 |
| Medtronic(2 entities) | 95 | $15,160 |
| Penumbra, Inc. | 55 | $11,284 |
| Bard Peripheral Vascular, Inc. | 81 | $3,460 |
| W. L. Gore & Associates, Inc. | 25 | $3,351 |
| Reflow Medical Inc | 17 | $2,769 |
| Inari Medical, Inc. | 29 | $1,853 |
| Celonova Biosciences, Inc. | 3 | $1,359 |
| Veryan Medical Incorporated | 11 | $1,058 |
| Cook Medical LLC | 14 | $946 |
| Silk Road Medical, Inc. | 8 | $496 |
| Boston Scientific | 7 | $374 |
| Terumo Medical Corporation | 14 | $362 |
| Shockwave Medical, Inc | 3 | $299 |
| Biotissue Holdings Inc. | 5 | $285 |
| Cvrx, Inc. | 3 | $241 |
| Inspiremd Ltd | 3 | $226 |
| Endologix LLC | 2 | $216 |
| Cardiovascular Systems Inc. | 9 | $213 |
| Impulse Dynamics (USA) Inc. | 1 | $202 |
| Cagent Vascular Inc | 1 | $162 |
| Abbott | 2 | $160 |
| Getinge USA Sales, LLC | 7 | $160 |
| BD | 2 | $138 |
| Avantec Vascular Corporation | 1 | $138 |
| Cordis US CORP. | 2 | $99 |
| Sanara Medtech Inc. | 1 | $93 |
| Avinger Inc. | 1 | $85 |
| Triad Life Sciences Inc. | 1 | $80 |
| Integra Lifesciences Corporation | 2 | $77 |
| Inquis Medical, Inc. | 1 | $73 |
| Bolton Medical Inc | 1 | $46 |
| Lemaitre Vascular, Inc. | 2 | $43 |
| Shape Memory Medical Inc. | 1 | $41 |
| Acera Surgical, Inc. | 1 | $39 |
| Philips North America LLC | 1 | $27 |
| Contego Medical, Inc | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Pounce Venous Thrombectomy System$62,599
- Pounce Thrombectomy$62,457
- Pounce Thrombectomy System$62,177
- Auryon Laser System 100-120 Vac$28,099
- Pounce LP Thrombectomy$20,699
- Sublime 014 Rx PTA Balloon Dilatation Catheter$19,182
- Pounce XL Thrombectomy$18,992
- Sublime Microcatheter, 018, 200cm, Straight$18,410
- PROWL Registry$15,349
- HawkOne$8,420
- Indigo System$7,656
- ENDURANT IIS$1,480
- Penumbra System$1,398
- GORE TAG Thoracic Endoprosthesis$1,050
- FLOWTRIEVER CATHETER, S$963
- Endurant$931
- Abre$903
- Sublime Radial Access 018 RX PTA Dilatation Catheter$771
- Sublime Radial Access Guide Sheath$771
- VIABAHN Endoprosthesis$715
How this compares
$140,756 in reported general payments places this provider in the 95th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 33 | $26,798 |
| EliquisApixaban | 23 | $17,674 |
| ClopidogrelClopidogrel Bisulfate | 118 | $1,014 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in San Antonio
- William EnglishSan Antonio$194K
- Nessa MillerSan Antonio$41K
- Lyssa OchoaSan Antonio$39K
- Ashton LeeSan Antonio$35K
- Andrew NagySan Antonio$35K
- Gregory PearlDallas$2.3M
- Mazin FotehAustin$1.6M
- Alan LumsdenHouston$742K
- Stephen HohmannDallas$499K
- Michael SiahDallas$392K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.